Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

AMCP 2026 26 - 29 October 2026

Characteristics associated with disease progression in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) treated with tafamidis

Authors :

Hanna K. Gaggin¹; Weilong Li²; Monika Semwal²; Ashley Goss²; Myriam Asmar²; Chioma Uzoigwe²; Yan Wang³; Ariel Chao³; Kat Wolf Khachatourian²; Yan Song⁴

Affiliations

View Details Hide Details

Download the poster (.pdf)

Keywords

Cardiology

Congress poster

RNAi

Pipeline

RWE